Congenital Heart Disease Clinical Trials in Rochester, Minnesota

7 studies are recruiting for congenital heart disease in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Invasive Hemodynamic for MACHD Registry

   This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mayo Clinic Rochester, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT05849025 on ClinicalTrials.gov

2. ATrial Tachycardia PAcing Therapy in Congenital Heart

   Congenital heart disease (CHD) affects approximately 1% of newborns in the US, with 25% of those affected having critical conditions requiring open heart surgery within one year of birth. Surgical and medical advances have allowed many patients to live beyond their fourth and fifth decades of life.…

   Stage

   Not phased

   Ages

   Any age

   Site

   Mayo Clinic, Rochester, Minnesota

   Locations

   15 in total

   Run by

   Ian Law

   See if you can join NCT03209583 on ClinicalTrials.gov

3. Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

   The goal of this clinical trial is to test the safety of lab-grown heart cells made from stem cells in subjects with congenital heart disease. The main questions it aims to answer are: * Is this product safe to deliver to humans * Is the conduct of this trial feasible Participants will be asked to:…

   Stage

   Phase 1

   Ages

   18 to 40

   Site

   Mayo Clinic, Rochester, Minnesota

   Run by

   HeartWorks, Inc.

   See if you can join NCT05647213 on ClinicalTrials.gov

4. A Study of Hemodynamic Cardiopulmonary Exercise for CHD

   The purpose of this study is to compare the difference in the ability to detect hemodynamic abnormalities between invasive hemodynamic assessments performed at rest versus exercise, to assess the correlation between invasive and noninvasive (Doppler-derived) rest-exercise hemodynamic indices and to…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mayo Clinic, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT06566196 on ClinicalTrials.gov

5. Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

   This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mayo Clinic in Rochester, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT05122962 on ClinicalTrials.gov

6. The Co-Op @ HeartWorks

   This protocol is a research study involving human subjects diagnosed with Congenital Heart Defects/Disease (CHD). The Co-Op @ HeartWorks is a cooperative between the research platform at HeartWorks and members of the CHD community. Individuals choosing to participate will be referred to as 'members…

   Stage

   Not phased

   Ages

   0 and older

   Site

   HeartWorks, Inc., Rochester, Minnesota

   Run by

   HeartWorks, Inc.

   See if you can join NCT06469918 on ClinicalTrials.gov

7. Effect of Sacubitril-Valsartan on Cardiac Structure and Function

   The purpose of this study is to compare changes in cardiac structure and function, biomarkers, and patient reported outcomes between adults with congenital heart disease (ACHD) randomized to angiotensin receptor-neprilysin inhibitor (ARNI) therapy vs placebo.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Mayo Clinic in Rochester, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT06693674 on ClinicalTrials.gov